To the Editor:
We would like to discuss the methodological issues of the interesting study by Sakai et al. [1] . To prove an association and causal relationship between a potential predictor and an outcome variable, Hill's criteria should be met [2, 3] . The criteria include strength, consistency, specificity, temporality, biological gradient (dose-response relationship), biological plausibility, coherence, experiment, and analogy. For example, as the remifentanil could result in vasodilation and increase in renal perfusion via suppression of vasopressin, there is a physiologic plausibility for remifentanil to decrease the risk of acute kidney injury (AKI). However, a significant association was not found, possibly due to small sample size. Regarding the dose-response relationship, the author's analysis seems to be insufficient. The remifentanil administration was evaluated only as a binomial variable in the multivariate analysis. The distribution of three different dose categories was shown in Fig. 2 . The dose-response relationship could be analyzed by adding these three dose categories to the multivariate analysis, Or, if the data on the remifentanil dose were available as a continuous variable, the dose of remifentanil as a continuous variable could be added to the multivariate analysis in their study or in a further prospective trial.
